Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

KalVista Pharmaceuticals (KALV) Profit After Tax (2016 - 2025)

Historic Profit After Tax for KalVista Pharmaceuticals (KALV) over the last 9 years, with Q2 2025 value amounting to -$52.2 million.

  • KalVista Pharmaceuticals' Profit After Tax fell 1697.01% to -$52.2 million in Q2 2025 from the same period last year, while for Apr 2025 it was -$166.3 million, marking a year-over-year decrease of 8575.15%. This contributed to the annual value of -$183.4 million for FY2025, which is 4485.01% down from last year.
  • KalVista Pharmaceuticals' Profit After Tax amounted to -$52.2 million in Q2 2025, which was down 1697.01% from -$40.4 million recorded in Q3 2024.
  • KalVista Pharmaceuticals' 5-year Profit After Tax high stood at -$29.0 million for Q1 2024, and its period low was -$52.2 million during Q2 2025.